Camurus AB (Camurus AB) Short Interest

View and export this data going back to 2017. Start your Free Trial

What is Camurus AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Camurus AB's Short Interest

For the Biotechnology subindustry, Camurus AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Camurus AB's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Camurus AB's Short Interest falls into.

Camurus AB (Camurus AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OTCPK:CAMRF) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

CAMX:Sweden 7CA:Germany 7CA:Germany

Address

Ideon Science Park, Lund, SWE, SE-223 70

Website

https://www.camurus.com

Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.